Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
Immunology and Cell Biology
|
November 10, 2022
High activation levels maintained in receptor-binding domain-specific memory B cells in people with severe coronavirus disease 2019
Money Gupta, Harikrishnan Balachandran, Raymond H Y Louie, et al.
Nature Communications
|
March 7, 2025
Structure and dynamics of GAD65 in complex with an autoimmune polyendocrine syndrome type 2-associated autoantibody
Susanne H D Ständer, Cyril F Reboul, Sarah N Le, et al.
Nature
|
August 10, 2022
The retroelement Lx9 puts a brake on the immune response to virus infection
Nenad Bartonicek, Romain Rouet, Joanna Warren, et al.
Cancer Research
|
June 3, 2011
Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer
Sandra A O'Toole, Dorothy A Machalek, Robert F Shearer, et al.
Science Advances
|
September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers
Yunguang Sun, Ning Yang, Fransiscus E Utama, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 2, 2025
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies
Ohan Mazigi, David B Langley, Jake Y Henry, et al.
Frontiers in Immunology
|
December 22, 2022
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells
Chansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, et al.
Ebiomedicine
|
September 21, 2022
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, et al.
Cell Reports. Medicine
|
March 22, 2021
Long-term persistence of RBD<sup>+</sup> memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
Arunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, et al.
Nature Communications
|
February 8, 2023
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Romain Rouet, Jake Y Henry, Matt D Johansen, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
Immunology and Cell Biology
|
November 10, 2022
High activation levels maintained in receptor-binding domain-specific memory B cells in people with severe coronavirus disease 2019
Money Gupta, Harikrishnan Balachandran, Raymond H Y Louie, et al.
Nature Communications
|
March 7, 2025
Structure and dynamics of GAD65 in complex with an autoimmune polyendocrine syndrome type 2-associated autoantibody
Susanne H D Ständer, Cyril F Reboul, Sarah N Le, et al.
Nature
|
August 10, 2022
The retroelement Lx9 puts a brake on the immune response to virus infection
Nenad Bartonicek, Romain Rouet, Joanna Warren, et al.
Cancer Research
|
June 3, 2011
Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer
Sandra A O'Toole, Dorothy A Machalek, Robert F Shearer, et al.
Science Advances
|
September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers
Yunguang Sun, Ning Yang, Fransiscus E Utama, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 2, 2025
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies
Ohan Mazigi, David B Langley, Jake Y Henry, et al.
Frontiers in Immunology
|
December 22, 2022
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells
Chansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, et al.
Ebiomedicine
|
September 21, 2022
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, et al.
Cell Reports. Medicine
|
March 22, 2021
Long-term persistence of RBD<sup>+</sup> memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
Arunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, et al.
Nature Communications
|
February 8, 2023
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Romain Rouet, Jake Y Henry, Matt D Johansen, et al.
Page
of 10